title: [Endocarditis due to Stenotrophomonas maltophilia].
authors.forename: Francisco Javier
authors.initials: FJ
authors.lastname: Candel
authors.forename: R
authors.initials: R
authors.lastname: López
authors.forename: A
authors.initials: A
authors.lastname: Valdivia
authors.forename: M J
authors.initials: MJ
authors.lastname: Núñez
authors.forename: V
authors.initials: V
authors.lastname: Roca-Arbonés
authors.forename: J J
authors.initials: JJ
authors.lastname: Picazo de la Garza
mesh_terms: D001022:Aortic Valve Insufficiency / Q000150:complications; D004198:Disease Susceptibility; D024901:Drug Resistance, Multiple, Bacterial; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000209:etiology / Q000382:microbiology*; D016905:Gram-Negative Bacterial Infections / Q000175:diagnosis / Q000382:microbiology*; D015658:HIV Infections / Q000150:complications; D006801:Humans; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000150:complications; D009055:Mouth / Q000382:microbiology; D015242:Ofloxacin / Q000627:therapeutic use; D012214:Rheumatic Heart Disease / Q000150:complications; D012307:Risk Factors; D020615:Stenotrophomonas maltophilia / Q000302:isolation & purification*; D015819:Substance Abuse, Intravenous; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
chemical_list: D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D015242:Ofloxacin